NEW YORK (360Dx) — Belgian diagnostics firm VolitionRx announced today that it is planning a partnership with Shanghai Fosun Long March Medical Science to introduce its NuQ blood-based cancer diagnostic platform in China.
NEW YORK (360Dx) — Belgian diagnostics firm VolitionRx announced today that it is planning a partnership with Shanghai Fosun Long March Medical Science to introduce its NuQ blood-based cancer diagnostic platform in China.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.